Shuttle Pharmaceuticals Transforms into Dogecoin Mining Powerhouse

The latest update is out from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ).

On April 30, 2026, Shuttle Pharmaceuticals signed a definitive agreement to acquire United Dogecoin, merging it into a wholly owned subsidiary in a stock deal built around newly created Series B-1 preferred shares and milestone-based pre-funded warrants. Shuttle simultaneously arranged an $11 million PIPE financing via Series B-2 preferred shares and warrants, and amended a prior asset purchase agreement, moves that collectively pivot the company toward becoming, by hash-rate share, the world’s largest publicly listed Dogecoin miner while running the legacy pharma-AI business in a separate subsidiary.

United Dogecoin’s management, led by CEO Ryan Trasolini who will become Shuttle’s co-CEO, plans to order up to 3,000 new ElphaPex rigs to reach as much as 1.5% of global Dogecoin hash power within about 60 days of funding, targeting low-cost, behind-the-meter renewable energy to mine DOGE more cheaply than buying it on the market. The complex capital structure, including large blocks of convertible preferred stock and milestone-linked pre-funded warrants for United Dogecoin holders, PIPE investors, advisors and a prior seller, concentrates future dilution around stockholder approvals and operational milestones, reshaping Shuttle into a highly leveraged Dogecoin mining and holding vehicle with significant upside and execution risk for existing shareholders.

Spark’s Take on SHPH Stock

According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.

Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.

To see Spark’s full report on SHPH stock, click here.

More about Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., listed on Nasdaq as SHPH, owns an AI-driven pharmaceutical software platform for molecular discovery and early-stage drug development. Its Molecule.ai system uses modern artificial intelligence and structured scientific workflows to help researchers explore chemical space more efficiently and make better-informed early drug design decisions.

United Dogecoin Inc. is a Dogecoin mining company focused on high-efficiency, low-cost mining and strategic accumulation of mined coins. Leveraging scale, preferential access to ElphaPex mining hardware and a team with a track record in public crypto miners, it aims to build a leading position in the Dogecoin sector through large hash-rate deployment and low-cost renewable energy sourcing.

Average Trading Volume: 340,179

Technical Sentiment Signal: Sell

Current Market Cap: $5.71M

For a thorough assessment of SHPH stock, go to TipRanks’ Stock Analysis page.